top of page

Study of neutralizing [anti-RBD] antibody responses induced by COVID-19 vaccines in healthcare professionals in a diagnostic centre of Central India

Updated: Mar 26

Original Article

Author Details : Ranjana Hawaldar*, Sadhna Sodani, Varsha Sodani, R K Sodani

Volume : 8, Issue : 2, Year : 2021

Article Page : 75-78




Abstract

Introduction: India began administration of COVID-19 vaccines on 16 January 2021. Reliable quantification of the antibody response to SARS-CoV-2 vaccination is highly relevant for identifying possible vaccine efficiency and estimating the time of protection. Healthcare Professionals were the first group of beneficiaries of this vaccine.Objectives: we aimed to evaluate the neutralizing [anti-RBD] antibody responses induced by COVID-19 vaccines after first and booster dose in healthcare professionalsMaterials and Methods: 69 healthcare professionals [HCPs] Were enrolled for the evaluation study. The COVISHILED vaccine developed by AstraZeneca, University of Oxford and manufactured and distributed in India by the Serum Institute of India was administered to all the participants. All participants were evaluated to detect levels neutralizing IgG antibodies on three occasions:,first pre vaccination level, second on approximately 27th day and third on 68th day from baselining & first vaccine dose to assess change in levels of neutralizing IgG antibodies post vaccinationResults: On approximately 27 day from first vaccine dose, 45 out of 51 participants in investigational cohort were sero-converted for anti-RBD antibodies. Out of 6 participants that were yet to sero-convert 5 demonstrated increased level of neutralizing [anti-RBD] antibodies but did not cross the reactivity threshold to confirm presence of neutralizing [anti-RBD] antibodies.On approximately 68 day from second vaccine dose, 49 out of 51 participants in investigational cohort were sero-converted for anti-RBD antibodies. 4 additional participants sero-converted post booster dose .96.0% produced neutralizing [anti-RBD] antibodies post vaccination. 2 participants continued to remain non-reactive.Conclusion: This is the first data of serological responses to COVID-19 vaccines in IBD patients with detailed analysis of antibodies RBD/spike proteins represented amongst HCPs from central India. Study also demonstrates that the level of neutralizing antibodies produced may vary due to several contributing factors and hence periodic monitoring of neutralizing antibodies before and post vaccination can help evaluate adaptive immune response induced by specific individual in response to vaccine administered.Keywords : Vaccination, Covishield, Immunity, S1RBD, HCPs.


How to cite : Hawaldar R, Sodani S, Sodani V, Sodani R K, Study of neutralizing [anti-RBD] antibody responses induced by COVID-19 vaccines in healthcare professionals in a diagnostic centre of Central India. J Community Health Manag 2021;8(2):75-78


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.



Previous Article

Next Article



We recommend

  1. Efficacy of COVID-19 vaccine in elderly Indian population with Vitamin D and Iron deficiency Deepika Gujjarlapudi et al., IP Journal of Nutrition, Metabolism and Health Science, 2022

  2. Immunological response in health care workers post COVID-19 vaccination Kanwardeep Singh et al., Annals of Geriatric Education and Medical Sciences, 2023

  1. Vaccination Against Covid-19: Recommendations for Candidates and Transplant Recipients Raquel Silveira Bello Stucchi et al., Brazilian Journal of Transplantation - BJT, 2022

  2. Updated TCM Treatment in Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Edition) and Its Guidance on Preventing and Treating SARS-CoV-2 Omicron Variant Infection FANG Bangjiang QI Wensheng YANG Zhixu YE Yong LI Xucheng ZHOU Shuang LIU Li et al., Journal of Shaanxi University of Chinese Medicine, 2022


IndianJMicrobiolRes-9-2-99-105
.pdf
Download PDF • 1.54MB

For More Info Article


10 views0 comments

Recent Posts

See All

コメント


bottom of page